首页> 外国专利> Genetically engineered tumorigenic cell lines and use thereof for the testing of anti-tumor agents

Genetically engineered tumorigenic cell lines and use thereof for the testing of anti-tumor agents

机译:基因工程致瘤细胞系及其在测试抗肿瘤剂中的用途

摘要

Vectors comprising a nucleotide sequence of formula (I) or (II), are new. R-X-A-X-IRES-X-B-X-polyA (I) R-X-B-X-IRES-X-C-X-polyA (II) R is a regulatory sequence for constitutive or inducible gene expression; A is a gene coding for a protein capable of inducing tumorigenic growth of cells; IRES is a nucleotide sequence of cellular or synthetic origin that is responsible for internal initiation in the translation process Äinternal ribosomal entry siteÜ; B is a reporter gene encoding a detectable secreted protein; polyA is a nucleotide sequence for transcript poly-adenylation; C is a marker gene encoding a protein permitting resistance-based selection, and X is an optional linker sequence. Also claimed is a mammalian cell line stably transfected with a vector as described above.
机译:包含式(I)或(II)的核苷酸序列的载体是新的。 R-X-A-X-IRES-X-B-X-polyA(I)R-X-B-X-IRES-X-C-X-polyA(II)R是组成型或诱导型基因表达的调控序列; A是编码能够诱导细胞致瘤性生长的蛋白质的基因; IRES是细胞或合成来源的核苷酸序列,负责翻译过程“内部核糖体进入位点”的内部起始。 B是编码可检测的分泌蛋白的报道基因; polyA是用于转录多聚腺苷酸化的核苷酸序列; C是编码允许基于抗性选择的蛋白质的标记基因,而X是可选的接头序列。还要求保护用如上所述的载体稳定转染的哺乳动物细胞系。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号